Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
Ting Y. Wong, Katherine S. Lee, Brynnan P. Russ, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Bibliometric analysis of RNA vaccines for cancer
Yang Xue, Jian Kang, Zhaohui Xing, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 4
Influenza virus strains expressing SARS-CoV-2 receptor binding domain protein confer immunity in K18-hACE2 mice
Nathaniel A. Rader, Katherine S. Lee, Andrea N. Loes, et al.
Vaccine X (2024) Vol. 20, pp. 100543-100543
Open Access | Times Cited: 1
The identification and characterization of novel and improved antigens for next-generation pertussis vaccines
Gage M. Pyles
(2024)
Open Access | Times Cited: 1
Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2
Mariette Barbier, Katherine S. Lee, Mayur S. Vikharankar, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
Sergio A. Rodriguez‐Aponte, Neil C. Dalvie, Ting Y. Wong, et al.
Vaccine (2022) Vol. 41, Iss. 5, pp. 1108-1118
Open Access | Times Cited: 6
Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
Puthupparampil V. Scaria, Christopher G. Rowe, Beth B. Chen, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104739-104739
Open Access | Times Cited: 5
An ambient-temperature stable nanoparticle-based vaccine for nasal application that confers long-lasting immunogenicity to carried antigens
Adolfo Cruz-Reséndiz, Gonzalo Acero, Alicia Sampieri, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Intranasal self-amplifying RNA SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission
Madeleine F. Jennewein, Michael D. Schultz, Samuel Beaver, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs
Yoshihiro Watanabe, Natsuko Hosokawa, Misaki Yoshida, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 287-287
Open Access | Times Cited: 2
Diet induced obesity and type 2 diabetes drives exacerbated sex-associated disease profiles in K18-hACE2-mice challenged with SARS-CoV-2
Katherine S. Lee, Brynnan P. Russ, Ting Y. Wong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice
Katherine S. Lee, Nathaniel A. Rader, Olivia A. Miller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Modified PEG-Lipids Enhance the Nasal Mucosal Immune Capacity of Lipid Nanoparticle mRNA Vaccines
Meng Li, Jing Yi, Yicheng Lu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1423-1423
Open Access
SARS-CoV-2 Spike receptor-binding domain entrapped in mannose-conjugated chitosan nanoparticle vaccine delivered intranasal elicits local and systemic Th1 and Th2 immune responses in mice and antiviral efficacy in Syrian hamsters
Kairat Tabynov, Maxim Solomadin, Nurkeldi Turebekov, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein
Kentarou Waki, Hideki Tani, Yumiko Saga, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice
Bhawana Pandey, Zhengying Wang, Angela Jimenez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
The Development of a New Pertussis Booster Formulation via the Implementation of New Adjuvants and Utilization of Alternate Routes of Administration
Megan A. DeJong
(2023)
Open Access
Targeted lipid A modification ofShigellavaccine strains reduced endotoxicity without compromising immunogenicity or invasiveness
Matthew E. Sherman, Jane Michalski, Sayan Das, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein
Kentarou Waki, Hideki Tani, Yumiko Saga, et al.
(2023)
Open Access
Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein
Kentarou Waki, Hideki Tani, Eigo Kawahara, et al.
eLife (2023)
Open Access
Utilizing the K18-hACE2 mouse model to develop protective COVID-19 vaccines
Ting Y. Wong
(2022)
Open Access
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
Sergio A. Rodriguez‐Aponte, Neil C. Dalvie, Ting Y. Wong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Previous Page - Page 2

Scroll to top